Safety and Efficacy of CT0494BCP in Participants With Advanced Gastric/Esophagogastric Junction Adenocarcinoma

NCT07538856 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Gastric
Gastric / Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG: Initial Dose (Dose Group 1)
DRUG: Dose Group 2
DRUG: Dose Group 3
DRUG: Dose Group 4
DRUG: Dose Group 5
DRUG: Dose Group 6

Sponsor

Beijing GoBroad Hospital